What is Atherotech?
Atherotech operates within the dynamic medical technology sector, as evidenced by its association with Med Tech Daily, a news platform dedicated to updates and insights in medicine, radiology, cardiology, and public health. Med Tech Daily focuses on informing healthcare professionals and the public about the latest advancements and innovations, including AI in healthcare and new medical devices. Atherotech's involvement in this space suggests a focus on developing or distributing cutting-edge medical technologies.
How much funding has Atherotech raised?
Atherotech has raised a total of $7.5M across 1 funding round:
Debt
$7.5M
Debt (2005): $7.5M with participation from ORIX
Key Investors in Atherotech
ORIX
ORIX, a diversified financial services group founded in 1964, offers a wide array of services including financing, investment, and banking. Their broad operational scope suggests a strategic interest in supporting companies with significant growth potential across various sectors.
What's next for Atherotech?
With a major enterprise-level funding context, Atherotech is poised for significant expansion and market penetration. The capital raised is expected to fuel further research and development, enhance product offerings, and potentially broaden its market reach. Strategic investments at this stage typically support scaling operations, increasing manufacturing capabilities, and strengthening distribution networks. Atherotech's future endeavors will likely focus on solidifying its position as a key player in the med-tech industry, leveraging its recent financial momentum to drive innovation and capture greater market share.
See full Atherotech company page
